Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study
2018 · EBioMedicine · 92 citations
https://doi.org/10.1016/j.ebiom.2018.09.023
Y
Yanna Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
309
Papers
4.8K
Citations
36
h-index
114
i10-index
Yanna Liu is an academic researcher from Pennsylvania State University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 36, co-authored 263 publications.
ORCID: 0000-0002-6573-4318Papers by this author
worksmiR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9 in H. pylori gastric cancer models
2017 · Scientific Reports · 80 citations
https://doi.org/10.1038/s41598-017-07193-w
Toxicity of Tetrabromobisphenol A and Its Derivative in the Mouse Liver Following Oral Exposure at Environmentally Relevant Levels
2021 · Environmental Science & Technology · 69 citations
https://doi.org/10.1021/acs.est.1c01726
Surface and interface control of black phosphorus
2021 · Chem · 60 citations
https://doi.org/10.1016/j.chempr.2021.11.022
Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer
2013 · Breast Cancer Research · 54 citations
https://doi.org/10.1186/bcr3374
Macrophage selective photodynamic therapy by meta-tetra(hydroxyphenyl)chlorin loaded polymeric micelles: A possible treatment for cardiovascular diseases
2017 · European Journal of Pharmaceutical Sciences · 46 citations
https://doi.org/10.1016/j.ejps.2017.06.038
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat